| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |